Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
CA81732W1041
Fri, 27.09.2024
Sernova Corp
Company Name:
Sernova Corp
ISIN:
CA81732W1041
Reason for the research:
Update
Recommendation:
Buy
from:
27.09.2024
Target price:
CAD1.90
Target price on sight of:
12 months
Last rating change:
-
Analyst:
Christian Orquera
First Berlin Equity Research has published a research update on Sernova Corp. (ISIN: CA81732W1041). Analys [ … ]
Tue, 06.02.2024
Sernova Corp
First Berlin Equity Research has published a research update on Sernova
Corp. (ISIN: CA81732W1041). Analyst Christian Orquera reiterated his BUY
rating and maintained his CAD 3.80 price target.
Abstract:
Sernova has published FY 22/23 financial statements and provided a business
update. The figures were roughly as expected. The company reported [ … ]
Thu, 19.10.2023
Sernova Corp
First Berlin Equity Research has initiated coverage on Sernova Corp (ISIN:
CA81732W1041). Analyst Christian Orquera's rating is BUY with a price
target of CAD3.80 (USD2.80; €2.60).
Abstract:
Sernova Corp (Sernova) is a Canadian, clinical-stage biotech company
developing cell therapeutics towards 'functional cures' for chronic
debilitating [ … ]
Thu, 14.09.2023
Sernova Corp.
LONDON, Ontario; WINDHAM COUNTY, Connecticut – September 14, 2023 – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, today announced it has rescheduled the investor and analyst conference call previously scheduled for September 15 at 10 a.m. Eastern Time. The call will now occur on Sep [ … ]
Wed, 13.09.2023
Sernova Corp.
- Introduction of New CEO Cynthia Pussinen and Recently Appointed Chief Business Officer, Dr. Modestus Obochi, on September 15, 2023 -
- Business Update, Strategy & Outlook Call on October 5, 2023 -
LONDON, Ontario; WINDHAM COUNTY, Connecticut – September 13, 2023 – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage compa [ … ]
Wed, 03.05.2023
Sernova Corp.
LONDON, Ontario – May 3, 2023 – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, today announced it has entered into a preclinical research collaboration with AstraZeneca (LSE/STO/Nasdaq:AZN) to evaluate the use of Sernova’s Cell Pouch System™ in combination with AstraZeneca’s novel th [ … ]
Wed, 03.05.2023
Sernova Corp.
LONDON, Ontario – May 3, 2023 – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, today announced it has entered into a preclinical research collaboration with AstraZeneca (LSE/STO/Nasdaq:AZN) to evaluate the use of Sernova’s Cell Pouch System™ in combination with AstraZeneca’s novel th [ … ]
Mon, 10.04.2023
Sernova Corp.
LONDON, Ontario – April 10, 2023 – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, today announced that President and Chief Executive Officer, Dr. Philip Toleikis, will present at the upcoming annual Cell & Gene Meeting on the Med to be held April 12-14, 2023 at the Hotel Arts Bar [ … ]
Mon, 10.04.2023
Sernova Corp.
LONDON, Ontario – April 10, 2023 – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, today announced that President and Chief Executive Officer, Dr. Philip Toleikis, will present at the upcoming annual Cell & Gene Meeting on the Med to be held April 12-14, 2023 at the Hotel Arts Bar [ … ]
Wed, 22.03.2023
Sernova Corp.
Sernova Announces Abstract on First Cohort of its Phase 1/2 Study Involving Islet Allotransplantation into Pre-vascularized Cell PouchTM Selected for Oral Podium Presentation at American Diabetes Association 83rd Scientific Sessions 2023
LONDON, Ontario – March 22, 2023 – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage com [ … ]